80 related articles for article (PubMed ID: 3002934)
1. Impaired pancreatic polypeptide response to insulin hypoglycemia in obese subjects.
Lassmann V; Cabrerizzo Garcia L; Vialettes B; Vague P
Horm Metab Res; 1985 Dec; 17(12):663-6. PubMed ID: 3002934
[TBL] [Abstract][Full Text] [Related]
2. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
3. Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man.
Seymour NE; Brunicardi FC; Chaiken RL; Lebovitz HE; Chance RE; Gingerich RL; Elahi D; Andersen DK
Surgery; 1988 Aug; 104(2):119-29. PubMed ID: 3041640
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
[TBL] [Abstract][Full Text] [Related]
5. Normal inhibition by somatostatin of glucose-stimulated B cell secretion in the obese subjects.
Bonora E; Moghetti P; Zancanaro C; Cigolini M; Querena M; Cacciatori V; Zenere M; Corgnati A; Muggeo M
Horm Metab Res; 1990 Nov; 22(11):584-8. PubMed ID: 1980259
[TBL] [Abstract][Full Text] [Related]
6. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
Rosenstock J; Foley JE; Rendell M; Landin-Olsson M; Holst JJ; Deacon CF; Rochotte E; Baron MA
Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance.
Glaser B; Zoghlin G; Pienta K; Vinik AI
Horm Metab Res; 1988 May; 20(5):288-92. PubMed ID: 3042579
[TBL] [Abstract][Full Text] [Related]
8. Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon.
Lefebvre PJ; Luyckx AS; Lecomte MJ
Horm Metab Res; 1976; Suppl 6():91-8. PubMed ID: 1278843
[TBL] [Abstract][Full Text] [Related]
9. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
10. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man.
Liu D; Moberg E; Kollind M; Lins PE; Adamson U
J Clin Endocrinol Metab; 1991 Nov; 73(5):1123-8. PubMed ID: 1682339
[TBL] [Abstract][Full Text] [Related]
11. Hormonal studies in a patient with PP-producing tumors.
Bordi C; Sivelli R; Lampugnani R; Zanella E; Fajans SS
Horm Metab Res; 1985 Sep; 17(9):467-70. PubMed ID: 3899891
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium infusion on post-reactive hypoglycemia.
Cathelineau G; Vexiau P; Guittard M
Horm Metab Res; 1981 Nov; 13(11):646-7. PubMed ID: 7030901
[TBL] [Abstract][Full Text] [Related]
13. Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.
Veedfald S; Vedtofte L; Skov-Jeppesen K; Deacon CF; Hartmann B; Vilsbøll T; Knop FK; Christensen MB; Holst JJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665480
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic glucagon response to glucose in obesity with normal and impaired carbohydrate tolerance.
Ratzmann KP; Schulz B; Witt S; Ziegler M
Int J Obes; 1981; 5(2):163-9. PubMed ID: 7014481
[TBL] [Abstract][Full Text] [Related]
15. Circulating amino acids and pancreatic endocrine function after ingestion of a protein-rich meal in obese subjects.
Schmid R; Schusdziarra V; Schulte-Frohlinde E; Maier V; Classen M
J Clin Endocrinol Metab; 1989 Jun; 68(6):1106-10. PubMed ID: 2656733
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.
Brunicardi FC; Chaiken RL; Ryan AS; Seymour NE; Hoffmann JA; Lebovitz HE; Chance RE; Gingerich RL; Andersen DK; Elahi D
J Clin Endocrinol Metab; 1996 Oct; 81(10):3566-72. PubMed ID: 8855802
[TBL] [Abstract][Full Text] [Related]
17. Activation of autonomic nerves and the adrenal medulla contributes to increased glucagon secretion during moderate insulin-induced hypoglycemia in women.
Havel PJ; Ahren B
Diabetes; 1997 May; 46(5):801-7. PubMed ID: 9133547
[TBL] [Abstract][Full Text] [Related]
18. Autonomic mediation of glucagon secretion during insulin-induced hypoglycemia in rhesus monkeys.
Havel PJ; Valverde C
Diabetes; 1996 Jul; 45(7):960-6. PubMed ID: 8666149
[TBL] [Abstract][Full Text] [Related]
19. Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man.
Ahrén B; Pacini G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3350-6. PubMed ID: 9745453
[TBL] [Abstract][Full Text] [Related]
20. Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene.
Ilag LL; Tabaei BP; Herman WH; Zawacki CM; D'Souza E; Bell GI; Fajans SS
Diabetes; 2000 Jun; 49(6):961-8. PubMed ID: 10866048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
